Vimarsana.com

Latest Breaking News On - Michael okunewitch - Page 8 : vimarsana.com

Bionano Genomics, Inc. (BNGO) CEO Erik Holmlin on Q1 2022 Results - Earnings Call Transcript

Bionano Genomics, Inc. (NASDAQ:NASDAQ:BNGO) Q1 2022 Earnings Conference Call May 5, 2022 04:30 PM ET Company Participants Amy Conrad - Investor Relations Erik Holmlin - Chief Executive.

China
United-states
American
Erik-holmlin
Amy-conrad
Chris-stewart
Michael-okunewitch
Company-participants
Michael-okunewitch-at-maxim-group
World-health-organization
Bionano-genomics-inc
Nasdaq

Volition Rx Limited (VNRX) Q1 2021 Earnings Call Transcript

Operator Good morning, ladies and gentlemen. Thank you for standing by. Welcome to VolitionRx Limited First Quarter 2021 Earnings Conference Call. [Operator Instructions] This conference is being recorded today, May 12, 2021. I would now like to turn the conference call over to Mr. Scott Powell, Executive Vice President of Investor Relations. Please go ahead. Scott Powell Executive Vice President, Investor Relations & Chief Financial Officer of Volition America, Inc. Thank you, and welcome everyone to today s earnings conference call for VolitionRx Limited. This call will cover Volition s financial and operating results for the first quarter of 2021, along with a discussion of our recent activities and key upcoming milestones. Following our prepared remarks, we will open the conference call to a question-and-answer session. On our call today are Mr. Cameron Reynolds, President and Chief Executive Officer; Mr. Terig Hughes, our Chief Financial Officer.

Florida
United-states
Taiwan
United-kingdom
Texas
London
City-of
America
Nathan-weinstein-agesi
Michael-okunewitch
Kyle-mikson
Bruce-jackson

vimarsana © 2020. All Rights Reserved.